Akeso, Inc. (HKG:9926)
Hong Kong · Delayed Price · Currency is HKD 176.90
+8.90 (5.30%)
Aug 22, 2025, 4:08 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 158.78 billion as of August 22, 2025. Its market cap has increased by 333.52% in one year.
Market Cap
158.78B
Enterprise Value
155.10B
Revenue
2.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
176.90
Market Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 158.78B, an increase of 756.23%. That is a compound annual growth rate of 49.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 158.78B | 191.43% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | 29.91B | 61.28% |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 265.89B |
| Hansoh Pharmaceutical Group Company | 213.81B |
| JD Health International | 203.69B |
| Innovent Biologics | 162.11B |
| Sino Biopharmaceutical | 133.42B |
| WuXi Biologics | 124.64B |
| CSPC Pharmaceutical Group | 119.93B |
| Sichuan Kelun-Biotech Biopharmaceutical | 98.50B |